First Time Loading...

BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 30.1 USD 0.43% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

849.3m
+55%
Assets
Growth Rates:
1 Year
+36%
3 Years
-22%
5 Years
+112%
7 Years
-
10 Years
-
1.9B
-0.1%
Liabilities
Growth Rates:
1 Year
+3%
3 Years
+28%
5 Years
+1 173%
7 Years
-
10 Years
-
-1B
+23%
Equity
Growth Rates:
1 Year
+14%
3 Years
-166%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
BridgeBio Pharma Inc

849.3m
Assets
1.9B
Liabilities
849.3m
Assets
1.9B
Liabilities
Current Assets 783.4m
Cash & Short-Term Investments 564.2m
Other Current Assets 219.3m
Non-Current Assets 65.9m
PP&E 19.5m
Intangibles 25.7m
Other Non-Current Assets 20.7m
Current Liabilities 141.5m
Accounts Payable 4.7m
Accrued Liabilities 122.8m
Other Current Liabilities 14m
Non-Current Liabilities 1.8B
Long-Term Debt 1.7B
Other Non-Current Liabilities 41.5m

Balance Sheet
BridgeBio Pharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
92
436
364
356
394
377
376
Cash Equivalents
92
436
364
356
394
377
376
Short-Term Investments
0
0
182
251
443
95
59
Other Current Assets
5
9
23
36
52
77
43
Total Current Assets
97
445
569
643
889
549
478
PP&E Net
0
2
6
37
46
25
20
PP&E Gross
0
2
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
45
29
26
Long-Term Investments
0
17
31
0
0
0
59
Other Long-Term Assets
1
1
26
24
33
20
23
Total Assets
98
N/A
465
+374%
632
+36%
704
+11%
1 013
+44%
623
-38%
546
-12%
Liabilities
Accounts Payable
2
14
9
9
12
12
11
Accrued Liabilities
6
15
48
80
123
102
127
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
2
0
0
0
Other Current Liabilities
1
4
4
6
0
8
6
Total Current Liabilities
9
33
60
96
135
121
144
Long-Term Debt
0
55
92
477
1 705
1 708
1 727
Minority Interest
3
63
68
50
5
10
12
Other Liabilities
0
1
4
23
38
39
18
Total Liabilities
12
N/A
150
+1 130%
223
+49%
646
+189%
1 883
+192%
1 878
0%
1 901
+1%
Equity
Common Stock
147
482
0
0
0
0
0
Retained Earnings
61
167
440
889
1 437
1 918
2 561
Additional Paid In Capital
0
0
848
1 021
842
939
1 481
Treasury Stock
0
0
0
75
275
275
275
Other Equity
0
0
0
0
0
0
0
Total Equity
86
N/A
315
+267%
409
+30%
58
-86%
870
N/A
1 255
-44%
1 354
-8%
Total Liabilities & Equity
98
N/A
465
+374%
632
+36%
704
+11%
1 013
+44%
623
-38%
546
-12%
Shares Outstanding
Common Shares Outstanding
115
115
124
123
147
151
175

See Also

Summary
BBIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BBIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BBIO stock valuation using valuation multiples.
Wall Street Estimates
BBIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BBIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.